# Security Posture — Executive Summary

> **Fictional company — portfolio/educational purposes only.**
>
> **Document Status:** Draft v1.0 | Owner: AppSec | Phase: P4
>
> **Audience:** Board of Directors, Executive Team, Health System CISOs
> **Date:** End of Phase 4 — AppSec Program Year 1

---

## What MedScribe-R-Us Protects

MedScribe-R-Us processes Protected Health Information (PHI) for every appointment
recorded on its platform. Each session involves a patient's voice, their clinical
history, and the AI-generated medical record that gets written to their permanent
Electronic Medical Record. The data is sensitive by nature and regulated by HIPAA,
under which MedScribe-R-Us operates as a Business Associate for every health system
customer.

A security failure at MedScribe-R-Us is not a data breach in the abstract. It is
a patient's medical history in the wrong hands, a fraudulent clinical note in their
permanent record, or — in the most severe scenario — a clinical decision made on
the basis of AI-generated content that was manipulated by an attacker.

This summary describes the security program built in Year 1 to prevent those outcomes.

---

## Current Security Posture

**Overall:** Strong foundation. Material risks identified, documented, and addressed.
Three AI pipeline risks require ongoing monitoring through the program's AI security
controls. No open Critical findings.

| Domain | Status | Summary |
|---|---|---|
| Threat Model | ✅ Complete | 14 findings identified and fully documented |
| Open Critical Findings | ✅ Zero | All 9 Critical findings remediated |
| CI/CD Security Gates | ✅ Active | 5-tool pipeline; blocking on Critical/High |
| PHI Access Controls | ✅ Implemented | RBAC + ABAC enforced; care team validation |
| Audit Logging | ✅ Implemented | Tamper-evident; 6-year retention |
| Network Security | ✅ Implemented | Single internet ingress; VPC Service Controls |
| AI Pipeline Security | ✅ Implemented | PHI scrubbing + output validation + injection testing |
| SLA Compliance | ⚠️ 91% | Target 95%; improving; no Critical SLA breaches |
| Program Maturity | ⚠️ 1.93/3.0 | Appropriate for Year 1; Year 2 target: 2.80 |
| Incident Response | 🔲 Partial | Escalation paths defined; playbook planned Year 2 |
| External Validation | 🔲 Planned | Private bug bounty active; third-party pentest Year 2 |

---

## What Was Built — Year 1

### Phase 0: Foundation
Defined the company's data classification framework (five tiers from PHI to Public),
established regulatory scope (HIPAA, SOC 2, HITRUST, OWASP LLM Top 10), and
documented the complete system architecture as the baseline for all security work.

### Phase 1: Threat Model
Produced a formal threat model of the entire platform including the AI pipeline —
an analysis not commonly performed for LLM-based healthcare systems. Identified
14 specific threats including 9 rated Critical, each with a documented impact,
likelihood, and remediation plan. The AI-specific threat model mapped MedScribe's
risks against the OWASP LLM Top 10 and MITRE ATLAS framework.

### Phase 2: CI/CD Security Pipeline
Deployed a five-tool automated security testing pipeline integrated into GitHub:
static analysis, dependency scanning, secrets detection, container scanning, and
dynamic application testing. Wrote custom security rules specific to MedScribe's
codebase covering PHI-in-logs patterns, missing authentication, and insecure
AI output handling. Every merge to main passes through these gates.

### Phase 3: Secure Architecture
Implemented and documented the secure architecture controls that address the
threat model findings: an IAM model combining role-based and attribute-based
access control for clinical context enforcement, PHI lifecycle documentation
tracing every data type from entry to deletion, and a GCP network security
design with a single internet ingress point enforced at the infrastructure layer.

### Phase 4: AI Security
Completed the AI-specific security work: a 10-case prompt injection test suite
covering direct and indirect injection vectors, a secure AI design guide defining
the PHI scrubbing validation requirements and output validation pipeline, and
this program maturity assessment. Established a private bug bounty program for
external security researcher validation.

---

## Material Risks — Current Status

### Resolved

**Cross-tenant data access (T-011):** A Clinic Admin could have accessed another
health system's patient data. Resolved by ABAC enforcement of `tenant_id` scope,
server-side JWT claims, and automated DAST validation.

**Approval gate bypass (T-009):** AI-generated notes could have reached the EMR
without clinician approval. Resolved by server-side approval state enforcement
in MongoDB with write-protected fields.

**PHI in application logs (T-006):** Patient data was at risk of appearing in
Datadog logs accessible to engineers. Resolved by custom SAST rules blocking
PHI variable names in log calls across the entire codebase.

**Credential/Secret Manager compromise (T-013):** A single compromised credential
could have yielded full system access. Resolved by VPC Service Controls perimeter
blocking external access to secrets even with valid credentials.

### Monitored (AI Pipeline)

**PHI scrubbing gap (T-007):** The NER model's false negative rate is a permanent
monitoring concern — an undetected PHI entity in a transcript would reach the Vertex
AI API. Mitigated by three-layer scrubbing (NER + regex + custom patterns),
mandatory 99.5% recall threshold on model validation, and output-side PHI scanning.
Status: controlled; requires ongoing validation.

**Indirect prompt injection (T-014):** Adversarially crafted prior notes from
Epic/Cerner could manipulate AI output. Mitigated by prior note content delimiting,
system prompt role assignment, and anomaly detection. Status: controlled; requires
ongoing test suite execution on every AI pipeline change.

---

## Regulatory Standing

| Framework | Current Status | Next Milestone |
|---|---|---|
| **HIPAA** | Controls implemented; all six Security Rule domains addressed | Annual risk analysis (Q1 Year 2) |
| **SOC 2 Type I** | Controls designed and documented | Type I audit readiness assessment (Q2 Year 2) |
| **SOC 2 Type II** | Observation period not yet started | Begin observation period (Q3 Year 2) |
| **HITRUST e1** | Self-assessment gap analysis planned | Gap analysis (Q2 Year 2) |
| **OWASP LLM Top 10** | Full mapping complete; controls implemented | Continuous (re-assess on model changes) |

---

## Year 2 Investment Priorities

| Initiative | Business Value | Est. Effort |
|---|---|---|
| Incident response playbook + tabletop | Required for HIPAA compliance; reduces breach response time | Medium |
| Third-party penetration test | External validation; required by enterprise health system customers | Medium |
| Security training curriculum | Reduces developer-introduced vulnerabilities; required for SOC 2 | Medium |
| SOC 2 Type II observation period | Required for enterprise contracts >$1M ACV | High |
| SIEM integration | Threat detection and operational visibility | High |
| HITRUST e1 gap analysis | Required by large health system enterprise contracts | Medium |

---

## One-Sentence Summary

MedScribe-R-Us has built a formal, documented security program in Year 1 that
identifies and addresses the material risks specific to an AI-powered healthcare
platform — including the AI pipeline threats that most security programs don't yet
know to look for — and is on track for SOC 2 Type II certification in Year 2.
